Creekmur Asset Management LLC Sells 2,321 Shares of Intuitive Surgical, Inc. $ISRG

Creekmur Asset Management LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 96.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 95 shares of the medical equipment provider’s stock after selling 2,321 shares during the quarter. Creekmur Asset Management LLC’s holdings in Intuitive Surgical were worth $42,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ISRG. Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after acquiring an additional 263,828 shares during the period. State Street Corp lifted its holdings in Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares in the last quarter. Norges Bank purchased a new stake in Intuitive Surgical in the 2nd quarter valued at about $2,569,260,000. Finally, Invesco Ltd. grew its stake in Intuitive Surgical by 4.8% in the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after acquiring an additional 201,159 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.7%

Shares of NASDAQ:ISRG opened at $503.51 on Monday. The company has a market capitalization of $178.81 billion, a PE ratio of 63.82, a P/E/G ratio of 3.88 and a beta of 1.66. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The business’s fifty day simple moving average is $529.83 and its 200-day simple moving average is $511.92.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the business posted $2.21 EPS. The firm’s quarterly revenue was up 18.8% on a year-over-year basis. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Gary S. Guthart sold 2,800 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the completion of the sale, the director directly owned 15,720 shares in the company, valued at $8,355,494.40. This trade represents a 15.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 33,603 shares of company stock worth $17,875,660. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Royal Bank Of Canada boosted their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Evercore decreased their target price on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research report on Friday, January 23rd. Argus lowered their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. The Goldman Sachs Group reissued a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Finally, BTIG Research restated a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.